The Food and Drug Administration recently issued a safety announcement to discuss the potentially serious side effects associated with certain antibacterial drugs. Fluoroquinolone is believed to have side effects which are severe enough that they should be avoided by patients who have other treatment options.
In 2009, President Obama signed the Family Smoking Prevention and Tobacco Control Act. This gave the FDA the authority to regulate tobacco products. In 2014 the FDA proposed recommendations for e-cigarettes that would require FDA review of existing and future products, warning labels, and a sales ban to individuals under the age of 18.
This past April, the FDA approved a new drug, targeting treatment for a form of leukemia that has been especially difficult to treat due to a specific chromosomal abnormality. The drug is called Venclexta and treats Chronic Lymphocytic Leukemia.
Each year, medication errors are among the leading causes or preventable deaths in the United States. The new rules are applicable to biologics, new drugs, over the counter medications, and generic drugs. This is a component of the overall initiative of the FDA to make drug safety a priority. The most common causes of medication […]
Recent media coverage surrounding the potential link between cancer and the use of a certain veterinary antibiotic has created a great deal of public concern. The news stories are based on an FDA press announcement regarding the potential decision to rescind its approval of treating swine with carbadox. The potential risk is associated with trace […]
According to recent data, about 20% of the United States population will suffer with some form of gastroesophageal reflux disease (GERD) in a given year. GERD is essentially chronic acid reflux, and it is becoming more common and more severe. Hospitalization for GERD rose by more than 200% between the years of 1998 and 2005.
In February, the Senate overwhelmingly voted to confirm the new commissioner of the FDA, Robert Califf. Califf was nominated by President Obama in September of 2015 for the position. Over the past few months, the nomination was contested for a variety of reasons before finally satisfying the Senate review.
Over the past several years, there has been a great deal of attention focused on the increasing number of individuals addicted to and abusing opioids. State legislatures, healthcare providers, and the federal government have all been looking at ways to reduce dependency.
